[PHARMA] QoQ TTM Result on 30-Sep-2016 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
21-Nov-2016
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2016
Quarter
30-Sep-2016 [#3]
Profit Trend
QoQ- -9.96%
YoY- -40.3%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Revenue 2,234,292 2,248,121 2,189,022 2,286,356 2,295,554 2,276,603 2,189,312 1.36%
PBT 61,919 73,256 72,017 91,665 97,079 100,648 112,722 -32.95%
Tax -21,162 -26,609 -26,158 -28,865 -26,952 -29,520 -28,138 -17.31%
NP 40,757 46,647 45,859 62,800 70,127 71,128 84,584 -38.56%
-
NP to SH 40,668 46,143 45,599 62,497 69,407 70,629 84,044 -38.39%
-
Tax Rate 34.18% 36.32% 36.32% 31.49% 27.76% 29.33% 24.96% -
Total Cost 2,193,535 2,201,474 2,143,163 2,223,556 2,225,427 2,205,475 2,104,728 2.79%
-
Net Worth 542,147 544,360 531,169 531,250 524,177 515,906 529,786 1.55%
Dividend
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Div 38,883 41,456 41,442 51,803 64,750 69,935 77,704 -36.99%
Div Payout % 95.61% 89.84% 90.88% 82.89% 93.29% 99.02% 92.46% -
Equity
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Net Worth 542,147 544,360 531,169 531,250 524,177 515,906 529,786 1.55%
NOSH 259,400 259,219 259,377 259,146 258,981 258,859 259,064 0.08%
Ratio Analysis
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
NP Margin 1.82% 2.07% 2.09% 2.75% 3.05% 3.12% 3.86% -
ROE 7.50% 8.48% 8.58% 11.76% 13.24% 13.69% 15.86% -
Per Share
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
RPS 861.33 867.27 844.83 882.26 886.38 879.48 845.08 1.27%
EPS 15.68 17.80 17.60 24.12 26.80 27.28 32.44 -38.43%
DPS 15.00 16.00 16.00 20.00 25.00 27.00 30.00 -37.03%
NAPS 2.09 2.10 2.05 2.05 2.024 1.993 2.045 1.46%
Adjusted Per Share Value based on latest NOSH - 259,146
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
RPS 155.02 155.98 151.88 158.64 159.27 157.96 151.90 1.36%
EPS 2.82 3.20 3.16 4.34 4.82 4.90 5.83 -38.40%
DPS 2.70 2.88 2.88 3.59 4.49 4.85 5.39 -36.95%
NAPS 0.3762 0.3777 0.3685 0.3686 0.3637 0.358 0.3676 1.55%
Price Multiplier on Financial Quarter End Date
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Date 30/06/17 31/03/17 30/12/16 30/09/16 30/06/16 31/03/16 31/12/15 -
Price 4.58 4.89 5.30 5.58 5.50 5.76 6.36 -
P/RPS 0.53 0.56 0.63 0.63 0.62 0.65 0.75 -20.67%
P/EPS 29.21 27.47 30.12 23.14 20.52 21.11 19.60 30.50%
EY 3.42 3.64 3.32 4.32 4.87 4.74 5.10 -23.40%
DY 3.28 3.27 3.02 3.58 4.55 4.69 4.72 -21.56%
P/NAPS 2.19 2.33 2.59 2.72 2.72 2.89 3.11 -20.86%
Price Multiplier on Announcement Date
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Date 16/08/17 16/05/17 21/02/17 21/11/16 19/08/16 13/05/16 15/02/16 -
Price 4.19 4.72 5.05 5.70 5.62 5.60 6.19 -
P/RPS 0.49 0.54 0.60 0.65 0.63 0.64 0.73 -23.35%
P/EPS 26.73 26.52 28.70 23.64 20.97 20.52 19.08 25.22%
EY 3.74 3.77 3.48 4.23 4.77 4.87 5.24 -20.15%
DY 3.58 3.39 3.17 3.51 4.45 4.82 4.85 -18.33%
P/NAPS 2.00 2.25 2.46 2.78 2.78 2.81 3.03 -24.20%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment